Univest
Univest
  • Markets

Pfizer Ltd. (PFIZER) Share Price Rises 5.24% Today on Market Update

  • October 13, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Pfizer Ltd. Share Price
Pfizer Ltd. (PFIZER) share price rose to Rs 4,080 today, up 5.24% from the previous close. Market cap was Rs 17,435.6 crore.

Pfizer Ltd. Share Price is trading at Rs 4,080, up 5.24% today, with market capitalisation at Rs 17,435.6 Cr. The move places Pfizer Ltd. Share Price in focus in healthcare trading today.

Pfizer Ltd. Share Price opened at Rs 3,876.8, matched the previous close, and moved higher to Rs 4,080. The stock is trading Rs 203.2 above the prior close, while market capitalisation stands at Rs 17,435.6 Cr. Univest data confirms the move itself, though no company-specific trigger has been identified. That makes the move a price action story first, with fundamentals and sector positioning providing the main context for readers tracking Pfizer Ltd. Share Price Today and Pfizer Ltd. Stock News. In the first part of the Pfizer Ltd. Share Price note, the day’s range, valuation and sector comparison matter more than conjecture. Investors watching Pfizer Ltd. Share Price can monitor whether the move stays aligned with the company’s earnings quality, return ratios and industry benchmark over the rest of the trading day.

Table of Contents

Toggle
  • Pfizer Ltd. Share Price Today: Price Action Analysis
  • Pfizer Ltd. (PFIZER) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching Pfizer Ltd.
  • About Pfizer Ltd.
  • Frequently Asked Questions
    • What is Pfizer Ltd. Share Price today?
    • Why is Pfizer Ltd. Share Price rising today?
    • What was the previous close for Pfizer Ltd. Share Price?
    • What does Pfizer Ltd. Share Price tell investors today?
    • How does Pfizer Ltd. compare with industry valuation?
    • Is Pfizer Ltd. Share Price expensive versus peers?
    • What are the key profitability ratios for Pfizer Ltd. Share Price?
    • What are the earnings and book value figures linked to Pfizer Ltd. Share Price?
  • Track Pfizer Ltd. Share Price on Univest

Pfizer Ltd. Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 4,080
Previous Close Rs 3,876.8
Today's Move Rs 203.2 (+5.24%)
Open Rs 3,876.8
High Rs 4,080
Low Rs 3,785.15
Market Capitalisation Rs 17,435.6 crore
Market Cap Category Mid Cap

Pfizer Ltd. (PFIZER) rose to Rs 4,080 from the previous close of Rs 3,876.8, a move of Rs 203.2 or 5.24%. The stock opened at Rs 3,876.8, reached a high of Rs 4,080, recorded a low of Rs 3,785.15.

Pfizer Ltd. Share Price is trading Rs 203.2 higher than the previous close, which works out to a 5.24% rise. The stock opened at Rs 3,876.8, touched a low of Rs 3,785.15 and reached Rs 4,080, which is also the day’s high. That leaves Pfizer Ltd. Share Price at the top of its visible intraday range so far. For readers following Pfizer Ltd. Share Price Today, the key facts are straightforward: the move is positive, the opening matched the prior close, and the latest trade stands at Rs 4,080. Pfizer Ltd. Share Price is therefore in the day’s list of rising names, but the visible data does not establish a company-specific reason. The next section turns from Pfizer Ltd. Share Price movement to fundamentals, where valuation and profitability metrics give the price move a deeper frame.

Pfizer Ltd. (PFIZER) Fundamental Analysis

Metric Value
Market Capitalisation Rs 17,435.6 crore
P/E Ratio 24.13x
P/B Ratio 4.02x
ROE 17.16%
ROCE 23.39%
EPS Rs 160.7
Book Value Per Share Rs 963.41
Dividend Yield 1.93%

Pfizer Ltd. (PFIZER) fundamental metrics show P/E 24.13x, P/B 4.02x, ROE 17.16%, ROCE 23.39%. Read together, these ratios describe the company’s position rather than a recommendation.

Pfizer Ltd. has a market capitalisation of Rs 17,435.6 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 24.13x, P/B at 4.02x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 17.16% and ROCE of 23.39%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 160.7, book value per share of Rs 963.41, dividend yield of 1.93%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.63x, median ROE of 11.61%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Pharmaceuticals & Drugs
Benchmark Scope same industry
Company P/E Ratio 24.13x
Benchmark Median P/E 31.63x
Benchmark Average P/E 47.13x
Benchmark P/E Range 3.21x to 676.52x
Company P/B Ratio 4.02x
Benchmark Median P/B 2.86x
Company ROE 17.16%
Benchmark Median ROE 11.61%
Company ROCE 23.39%
Benchmark Median ROCE 13.46%
Company Market Capitalisation Rs 17,435.6 crore
Benchmark Median Market Cap Rs 814.52 crore

Pfizer Ltd. (PFIZER) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Pfizer Ltd. (PFIZER) has a P/E ratio of 24.13x, which is below the benchmark median of 31.63x, a difference of -23.71%. The P/E comparison frames valuation; it is not a signal to buy or sell.

Pfizer Ltd. (PFIZER) has a ROE of 17.16%, which is above the benchmark median of 11.61%, a difference of +47.8%. Pfizer Ltd. (PFIZER) has a ROCE of 23.39%, which is above the benchmark median of 13.46%, a difference of +73.77%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Sun Pharmaceutical Industries Ltd. SUNPHARMA 4,21,539.16 34.89 4.88 14.85 19.11
Divi's Laboratories Ltd. DIVISLAB 2,47,576 85.12 14.1 16.19 21.51
Torrent Pharmaceuticals Ltd. TORNTPHARM 1,77,251.42 81.6 19.83 26.76 19.27
Zydus Lifesciences Ltd. ZYDUSLIFE 1,11,231.65 25.18 4.21 19.69 21.39
Laurus Labs Ltd. LAURUSLABS 1,09,796.85 102.34 19.84 18.31 18.2

Pfizer Ltd. (PFIZER) has a P/E ratio of 24.13x compared with the displayed peer median of 81.6x. Peer multiples give relative context only, not a buy or sell view. Its ROE of 17.16% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 23.39% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Pfizer Ltd. (PFIZER) has a market capitalisation of Rs 17,435.6 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Pfizer Ltd.

  • Pfizer Ltd. Share Price is up 5.24% today, making the stock one of the stronger names in the current trade.
  • The move leaves Pfizer Ltd. Share Price at Rs 4,080, with the day’s high also at Rs 4,080.
  • Pfizer Ltd. Share Price is supported by ROE of 17.16% and ROCE of 23.39%, both above industry medians.
  • Pfizer Ltd. Share Price trades at a P/E of 24.13, below the industry median and average.
  • Pfizer Ltd. Share Price also sits within a sector where valuation and return ratios are key markers for comparison.

About Pfizer Ltd.

Pfizer Ltd. operates in Healthcare and the Pharmaceuticals & Drugs industry. The company is part of a large listed universe where market cap, earnings quality and return ratios are central to comparison. For readers studying Pfizer Ltd. Share Price, the business context matters because the stock is not moving in a vacuum; it belongs to a sector where valuation and profitability are weighed together. Pfizer Ltd. is analysed here through its listed-market profile, including market capitalisation, P/E, P/B, EPS, book value, ROE, ROCE and dividend yield. That set of measures helps explain why Pfizer Ltd. Share Price can draw interest even on a day without a disclosed company-specific trigger. In this article, Pfizer Ltd. Share Price is therefore treated as both a market event and a company-level valuation case within the broader pharmaceutical universe.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

What is Pfizer Ltd. Share Price today?

Ans. Pfizer Ltd. Share Price is Rs 4,080 today. It is up 5.24% from the previous close of Rs 3,876.8, and the market capitalisation stands at Rs 17,435.6 Cr.

Why is Pfizer Ltd. Share Price rising today?

Ans. Pfizer Ltd. Share Price is rising, but no company-specific catalyst is established in the visible data. The confirmed facts are the Rs 203.2 gain, the 5.24% move and the day’s high of Rs 4,080.

What was the previous close for Pfizer Ltd. Share Price?

Ans. The previous close for Pfizer Ltd. Share Price was Rs 3,876.8. The stock opened at the same level and moved higher through the trading day to Rs 4,080.

What does Pfizer Ltd. Share Price tell investors today?

Ans. Pfizer Ltd. Share Price shows a positive intraday move backed by valuation and profitability context. The stock trades at P/E of 24.13, ROE of 17.16% and ROCE of 23.39%.

How does Pfizer Ltd. compare with industry valuation?

Ans. Pfizer Ltd. Share Price is below the industry median P/E of 31.63 and the industry average of 47.13. Its P/B of 4.02 is above the median of 2.86.

Is Pfizer Ltd. Share Price expensive versus peers?

Ans. Pfizer Ltd. Share Price sits below several peer P/E readings such as Divi’s Laboratories Ltd. at 85.12 and Torrent Pharmaceuticals Ltd. at 81.6. It is close to Zydus Lifesciences Ltd. at 25.18.

What are the key profitability ratios for Pfizer Ltd. Share Price?

Ans. Pfizer Ltd. Share Price is supported by ROE of 17.16% and ROCE of 23.39%. Both are above the industry median levels, which adds context to the current market move.

What are the earnings and book value figures linked to Pfizer Ltd. Share Price?

Ans. Pfizer Ltd. Share Price corresponds with EPS of 160.7 and book value of 963.41. These per-share figures help frame earnings power and accounting net worth behind the stock.

Track Pfizer Ltd. Share Price on Univest

Use Pfizer Ltd. (PFIZER) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Readers can track Pfizer Ltd. Share Price on Univest for live price movement, valuation ratios, market capitalisation, 52-week levels and market insights. The platform also helps compare Pfizer Ltd. Share Price Today with sector peers and broader industry benchmarks. For ongoing Pfizer Ltd. Stock News coverage, Univest keeps the focus on price action, fundamentals and sector context.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply